Advances in Precision Medicine for NSCLC: Expert Guidance for Community Practice

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Treatment Options for the Common Targetable Biomarkers for Advanced NSCLC: EGFR, KRAS, and HER2

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in NSCLC: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
An Expert’s Guide to ASCO 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints: Multidisciplinary Perspectives Informing Optimal Treatment of RET-Altered Lung and Thyroid Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Multidisciplinary Perspectives Informing Optimal Treatment of RET-Altered Lung and Thyroid Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
The Latest Evidence on Selective RET Inhibition in Advanced RET Fusion–Positive NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Insight on Therapy Selection for Unresectable Stage III and Metastatic NSCLC

Content Format:

Tool

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts for People With Unresectable Stage III or Metastatic NSCLC: An Online Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
How I Am Using Selective RET Inhibitors in Lung Cancer Care Today

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Emerging Therapies and Testing for METex14 in Advanced NSCLC

Content Format:

Text Module

Credit Type:

--

Credits:

--
Emerging Therapies and Testing for METex14 in Advanced NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How I Am Using Selective MET Inhibitors in Patients With MET Exon 14–Positive NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Overview of MET Exon 14 Mutation Testing and Treatment in Advanced NSCLC

Content Format:

Video

Credit Type:

--

Credits:

--
MET-Targeted Therapies in Development: Tepotinib, Crizotinib, Savolitinib, and Combinations

Content Format:

Slideset Download

Credit Type:

--

Credits:

--